# Safety and Efficacy Study of Lithium in Bipolar Disorder

> **NCT00422331** · PHASE3 · UNKNOWN · sponsor: **JDS Pharmaceuticals** · enrollment: 206 (estimated)

## Conditions studied

- Bipolar Disorder
- Mania

## Interventions

- **DRUG:** Lithium Carbonate Capsule

## Key facts

- **NCT ID:** NCT00422331
- **Lead sponsor:** JDS Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 206 (ESTIMATED)
- **Last updated:** 2007-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422331, "Safety and Efficacy Study of Lithium in Bipolar Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00422331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*